tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BBIO Stock Latest News

BridgeBio Pharma call volume above normal and directionally bullish
The FlyBridgeBio Pharma call volume above normal and directionally bullish
33m ago
BBIO
BridgeBio reports open-label extension data on acoramidis in ATTR-CM
PremiumThe Fly
BridgeBio reports open-label extension data on acoramidis in ATTR-CM
3d ago
BBIO
BridgeBio announces publication of PROPEL 2 data in NEJM
PremiumThe Fly
BridgeBio announces publication of PROPEL 2 data in NEJM
3d ago
BBIO
BridgeBio price target raised to $45 from $44 at Scotiabank
PremiumThe Fly
BridgeBio price target raised to $45 from $44 at Scotiabank
6d ago
ALNY
BBIO
BridgeBio Pharma Reports Quarterly Loss Amid Restructuring
PremiumCompany Announcements
BridgeBio Pharma Reports Quarterly Loss Amid Restructuring
8d ago
BBIO
BridgeBio reports Q3 EPS (86c), consensus (98c)
PremiumThe FlyBridgeBio reports Q3 EPS (86c), consensus (98c)
9d ago
BBIO
BridgeBio announces publication on impact of biomedical innovation
Premium
The Fly
BridgeBio announces publication on impact of biomedical innovation
16d ago
BBIO
BBIO Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
BBIO Upcoming Earnings Report: What to Expect?
23d ago
BBIO
BridgeBio shares preliminary data from CANaspire Phase 1/2 trial of BBP-812
PremiumThe Fly
BridgeBio shares preliminary data from CANaspire Phase 1/2 trial of BBP-812
28d ago
BBIO
BridgeBio price target lowered to $46 from $47 at Leerink
PremiumThe Fly
BridgeBio price target lowered to $46 from $47 at Leerink
1M ago
BBIO
Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
1M ago
EL
AAP
BridgeBio initiated with an Outperform at Scotiabank
PremiumThe Fly
BridgeBio initiated with an Outperform at Scotiabank
1M ago
BBIO
BridgeBio Pharma call volume above normal and directionally bullish
PremiumThe FlyBridgeBio Pharma call volume above normal and directionally bullish
1M ago
BBIO
BridgeBio presenting results of Phase 3 study of acoramidis in ATTR-CM
Premium
The Fly
BridgeBio presenting results of Phase 3 study of acoramidis in ATTR-CM
2M ago
BBIO
BridgeBio initiated with a Perform at Oppenheimer
Premium
The Fly
BridgeBio initiated with a Perform at Oppenheimer
2M ago
BBIO
BridgeBio completes enrollment of FORTIFY Phase 3 study of BBP-418
PremiumThe Fly
BridgeBio completes enrollment of FORTIFY Phase 3 study of BBP-418
2M ago
BBIO
Opening Day: Obesity drug developer BioAge makes Nasdaq debut
PremiumThe Fly
Opening Day: Obesity drug developer BioAge makes Nasdaq debut
2M ago
C
MS
BridgeBio presents post-hoc analysis evaluating acoramidis
PremiumThe Fly
BridgeBio presents post-hoc analysis evaluating acoramidis
2M ago
BBIO
BioMarin price target lowered to $90 from $118 at Truist
PremiumThe Fly
BioMarin price target lowered to $90 from $118 at Truist
2M ago
ASND
BBIO
BridgeBio announces FDA granted BTD to oral infigratinib
PremiumThe FlyBridgeBio announces FDA granted BTD to oral infigratinib
2M ago
BBIO
BioMarin price target lowered to $115 from $130 at BofA
Premium
The Fly
BioMarin price target lowered to $115 from $130 at BofA
2M ago
ASND
BBIO
BridgeBio to reduce gene therapy budget more than $50M
Premium
The Fly
BridgeBio to reduce gene therapy budget more than $50M
2M ago
BBIO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >